Let them wring their hands in stupidity, because there is no conclusion that can logically be drawn from this information. There a zillion things that could be going on now, and lots of good reasons not to release interim data.
The bashers are using this tempest in a teapot to try to bury the great news of Kevetrin clinical trial starting up at a 2nd site. This is very, very good news.
(4)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links